Cargando…
Median effective dose of esketamine for intranasal premedication in children with congenital heart disease
BACKGROUND: Esketamine is commonly used as a premedication for its sedation effect. However, the proper dosage for intranasal use in children with congenital heart disease (CHD) has not been determined. This study aimed to estimate the median effective dose (ED(50)) of esketamine for intranasal prem...
Autores principales: | Huang, Jiajia, Liu, Daoqing, Bai, Jie, Gu, Hongbin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10114298/ https://www.ncbi.nlm.nih.gov/pubmed/37076798 http://dx.doi.org/10.1186/s12871-023-02077-1 |
Ejemplares similares
-
Median Effective Dose of Intranasal Dexmedetomidine for Transthoracic Echocardiography in Children with Kawasaki Disease Who Have a History of Repeated Sedation
por: Gu, Hong-Bin, et al.
Publicado: (2019) -
Comparison of Intranasal Dexmedetomidine Compared to Midazolam as a Premedication in Pediatrics with Congenital Heart Disease Undergoing Cardiac Catheterization
por: Messeha, Medhat M., et al.
Publicado: (2018) -
ED50 of Intranasal Dexmedetomidine Sedation for Transthoracic Echocardiography in Children with or without a History of Cardiac Surgery for Cyanotic Congenital Heart Disease
por: Gu, HongBin, et al.
Publicado: (2020) -
Intranasal esketamine and the dawn of precision psychiatry
por: Watts, Devon, et al.
Publicado: (2021) -
Median effective dose (ED(50)) of esketamine combined with propofol for children to inhibit response of gastroscope insertion
por: Su, Ming, et al.
Publicado: (2023)